SCHEMBL4255092

SCHEMBL4255092

N#CC1C=CC=CC1c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CUL4A Q13619 1/20 0.33
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
PKM P14618 1/20 0.32
ALOX12 P18054 1/20 0.32
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
TSHR P16473 1/20 0.32
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
YWHAG P61981 1/20 0.31
HSD17B10 Q99714 1/20 0.31
GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4688615 0.98 CUL4A (0.32) CUL4AKDM4EALDH1A1HPGDPKM
SCHEMBL30311727 0.75 RECQL (0.40) TSHRMAPTHSD17B10RECQLSLC18A3
SCHEMBL28867323 0.70 CUL4A (0.36) CUL4ATSHRMEN1KMT2AHSD17B10
SCHEMBL22592092 0.69
SCHEMBL17518709 0.67 SMN1; SMN2 (0.33) TSHRMEN1MAPTKMT2AGAA
SCHEMBL31296475 0.66 PTGS2 (0.32) KDM4ETDP1MAPTHSD17B10
SCHEMBL14652740 0.65 MAOB (0.41) KDM4EHPGDTSHRMAPTHSD17B10
SCHEMBL21162132 0.65 MAOB (0.41) KDM4EHPGDTSHRMAPTHSD17B10
SCHEMBL28036409 0.65 CYP2C19 (0.42) TSHRMEN1KMT2AHSD17B10RECQL
SCHEMBL18570252 0.65 RECQL (0.33) TSHRMAPTHSD17B10RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2077719-A2 PIPERIDINE AND PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck and Co., Inc. (US) 2009-07-15 EP claimed
WO-2008036316-A2 PIPERIDINE AND PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-03-27 WO claimed
EP-1931655-A2 A PROCESS FOR THE PREPARATION OF SARTAN DERIVATIVES AND INTERMEDIATES USEFUL IN SUCH PROCESS KRKA, D.D., Novo Mesto (SI) 2008-06-18 EP disclosed
EP-1565443-A4 ACETYL 2-HYDROXY-1,3 DIAMINOALKANES ELAN PHARM INC (US) 2007-07-18 EP disclosed
WO-2007039117-A2 A PROCESS FOR THE PREPARATION OF SARTAN DERIVATIVES AND INTERMEDIATES USEFUL IN SUCH PROCESS KRKA, D.D., NOVO, MESTO (SI) 2007-04-12 WO disclosed
EP-1751091-A2 2-AMINO- AND 2-THIO-SUBSTITUTED 1,3-DIAMINOPROPANES Elan Pharmaceuticals, Inc. (US) 2007-02-14 EP disclosed
EP-1638941-A1 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS ABBOTT LABORATORIES (US) 2006-03-29 EP disclosed
WO-2005095326-A2 2-AMINO- AND 2-THIO-SUBSTITUTED 1,3-DIAMINOPROPANES ELAN PHARMACEUTICALS, INC. (US) 2005-10-13 WO disclosed
EP-1565443-A2 ACETYL 2-HYDROXY-1,3 DIAMINOALKANES Elan Pharmaceuticals, Inc. (US) 2005-08-24 EP disclosed
WO-2004113304-A1 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS ABBOTT LABORATORIES (US) 2004-12-29 WO disclosed
WO-2004024081-A2 ACETYL 2-HYDROXY-1,3 DIAMINOALKANES ELAN PHARMACEUTICALS, INC. (US) 2004-03-25 WO disclosed